196 related articles for article (PubMed ID: 19937936)
1. Guideline to use gadolinium-based contrast agents at Kyoto University Hospital.
Miki Y; Isoda H; Togashi K
J Magn Reson Imaging; 2009 Dec; 30(6):1364-5. PubMed ID: 19937936
[TBL] [Abstract][Full Text] [Related]
2. NSF prevention in clinical practice: summary of recommendations and guidelines in the United States, Canada, and Europe.
Leiner T; Kucharczyk W
J Magn Reson Imaging; 2009 Dec; 30(6):1357-63. PubMed ID: 19937935
[TBL] [Abstract][Full Text] [Related]
3. Gadolinium-based contrast agents and nephrogenic systemic fibrosis: why did it happen and what have we learned?
Weinreb JC; Abu-Alfa AK
J Magn Reson Imaging; 2009 Dec; 30(6):1236-9. PubMed ID: 19938035
[TBL] [Abstract][Full Text] [Related]
4. Removal of gadolinium by dialysis: review of different strategies and techniques.
Silberzweig JI; Chung M
J Magn Reson Imaging; 2009 Dec; 30(6):1347-9. PubMed ID: 19937933
[TBL] [Abstract][Full Text] [Related]
5. Nephrogenic systemic fibrosis.
Weinreb JC; Kuo PH
Magn Reson Imaging Clin N Am; 2009 Feb; 17(1):159-67. PubMed ID: 19364606
[TBL] [Abstract][Full Text] [Related]
6. Nephrogenic systemic fibrosis and its impact on abdominal imaging.
Prince MR; Zhang HL; Prowda JC; Grossman ME; Silvers DN
Radiographics; 2009 Oct; 29(6):1565-74. PubMed ID: 19959508
[TBL] [Abstract][Full Text] [Related]
7. Retrospective assessment of prevalence of nephrogenic systemic fibrosis (NSF) after implementation of a new guideline for the use of gadobenate dimeglumine as a sole contrast agent for magnetic resonance examination in renally impaired patients.
Abujudeh HH; Rolls H; Kaewlai R; Agarwal S; Gebreananya ZA; Saini S; Schaefer PW; Kay J
J Magn Reson Imaging; 2009 Dec; 30(6):1335-40. PubMed ID: 19937927
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for NSF: a literature review.
Prince MR; Zhang HL; Roditi GH; Leiner T; Kucharczyk W
J Magn Reson Imaging; 2009 Dec; 30(6):1298-308. PubMed ID: 19937930
[TBL] [Abstract][Full Text] [Related]
9. Gadolinium-based contrast agents and NSF: evidence from animal experience.
Sieber MA; Steger-Hartmann T; Lengsfeld P; Pietsch H
J Magn Reson Imaging; 2009 Dec; 30(6):1268-76. PubMed ID: 19938039
[TBL] [Abstract][Full Text] [Related]
10. Incidence of nephrogenic systemic fibrosis at Chinese PLA General Hospital.
Zou Z; Ma L; Li H
J Magn Reson Imaging; 2009 Dec; 30(6):1309-12. PubMed ID: 19937931
[TBL] [Abstract][Full Text] [Related]
11. How to avoid nephrogenic systemic fibrosis: current guidelines in Europe and the United States.
Thomsen HS
Radiol Clin North Am; 2009 Sep; 47(5):871-5, vii. PubMed ID: 19744601
[TBL] [Abstract][Full Text] [Related]
12. Gadolinium-associated nephrogenic systemic fibrosis.
Schlaudecker JD; Bernheisel CR
Am Fam Physician; 2009 Oct; 80(7):711-4. PubMed ID: 19817341
[TBL] [Abstract][Full Text] [Related]
13. Nephrogenic systemic fibrosis and the role of gadolinium contrast media.
van der Molen AJ
J Med Imaging Radiat Oncol; 2008 Aug; 52(4):339-50. PubMed ID: 18811757
[TBL] [Abstract][Full Text] [Related]
14. Current status of nephrogenic systemic fibrosis.
Daftari Besheli L; Aran S; Shaqdan K; Kay J; Abujudeh H
Clin Radiol; 2014 Jul; 69(7):661-8. PubMed ID: 24582176
[TBL] [Abstract][Full Text] [Related]
15. Incidence of nephrogenic systemic fibrosis after adoption of restrictive gadolinium-based contrast agent guidelines.
Wang Y; Alkasab TK; Narin O; Nazarian RM; Kaewlai R; Kay J; Abujudeh HH
Radiology; 2011 Jul; 260(1):105-11. PubMed ID: 21586680
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of NSF: New evidence challenging the prevailing theory.
Newton BB; Jimenez SA
J Magn Reson Imaging; 2009 Dec; 30(6):1277-83. PubMed ID: 19937925
[TBL] [Abstract][Full Text] [Related]
17. Update on nephrogenic systemic fibrosis.
Thomsen HS; Marckmann P; Logager VB
Magn Reson Imaging Clin N Am; 2008 Nov; 16(4):551-60, vii. PubMed ID: 18926421
[TBL] [Abstract][Full Text] [Related]
18. Nephrogenic systemic fibrosis: clinical spectrum of disease.
Mayr M; Burkhalter F; Bongartz G
J Magn Reson Imaging; 2009 Dec; 30(6):1289-97. PubMed ID: 19937929
[TBL] [Abstract][Full Text] [Related]
19. Nephrogenic systemic fibrosis and management of high-risk patients.
Altun E; Semelka RC; Cakit C
Acad Radiol; 2009 Jul; 16(7):897-905. PubMed ID: 19375360
[TBL] [Abstract][Full Text] [Related]
20. Nephrogenic systemic fibrosis: pathogenesis, diagnosis, and therapy.
Kribben A; Witzke O; Hillen U; Barkhausen J; Daul AE; Erbel R
J Am Coll Cardiol; 2009 May; 53(18):1621-8. PubMed ID: 19406336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
